Results for the second quarter and first half 2018 for Medistim ASA

Sales ended at MNOK 76.2 for the quarter (MNOK 69.2), a 10.2 % increase. Sales for the 1st half increased by 4.7 % and ended at MOK 150.4 (MNOK 143.5). Currency neutral growth of own products was 19.3 % for the quarter. Currency neutral growth of own products was 8.2 % for the 1st half. Operating profit (EBIT) for the quarter ended at MNOK 18.1 (MNOK 13.6). Operating profit for the 1st half ended at MNOK 31.7 (MNOK 29.7). Medistims equipment received an updated recommendation by NICE in UK during the first half of 2018. The first results from the REQUEST register study was presented during AATS. The study documents improved surgical outcome when Medistims equipment is used during surgery. Dividend based upon 2017 results was paid the second quarter with MNOK 36.4, NOK 2.00 per share (NOK 1.75 per share).